The Interleukin-17 Pathway in Psoriasis and Psoriatic Arthritis: Disease Pathogenesis and Possibilities of Treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Interleukin-17 Pathway in Psoriasis and Psoriatic Arthritis: Disease Pathogenesis and Possibilities of Treatment
Authors
Keywords
Psoriatic arthritis, Psoriasis, Interleukin-17, IL-17, Interleukin-23, IL-23, Biologic agents, Pathogenesis, Treatment
Journal
Current Rheumatology Reports
Volume 16, Issue 4, Pages -
Publisher
Springer Nature
Online
2014-02-25
DOI
10.1007/s11926-014-0414-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Functional Roles for Both IL-17RB and IL-17RA in Mediating IL-25-Induced Activities
- (2014) E. A. Rickel et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: An IL-17F-CreEYFP Reporter Mouse Allows Fate Mapping of Th17 Cells
- (2014) A. L. Croxford et al. JOURNAL OF IMMUNOLOGY
- Long-term safety of ustekinumab for psoriasis
- (2013) Neal Kumar et al. Expert Opinion On Drug Safety
- Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis
- (2013) Takatoshi Shimauchi et al. JOURNAL OF DERMATOLOGY
- Ustekinumab for Resistant Psoriatic Arthritis
- (2013) D. E. J. WALLIS et al. JOURNAL OF RHEUMATOLOGY
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires
- (2012) Muhammad Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis
- (2012) Nataliya Yeremenko et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- γδ-T cells: an unpolished sword in human anti-infection immunity
- (2012) Jian Zheng et al. Cellular & Molecular Immunology
- Primed for inflammation: enthesis-resident T cells
- (2012) Rik J Lories et al. NATURE MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis
- (2011) Lihi Eder et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype
- (2011) Robert Winchester et al. ARTHRITIS AND RHEUMATISM
- Orphan Cytokine Reveals IL-17 Family Secret
- (2011) Christopher J. Haines et al. IMMUNITY
- Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) -- Report of the OMERACT 10 PsA Special Interest Group
- (2011) L. C. COATES et al. JOURNAL OF RHEUMATOLOGY
- IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens
- (2011) Xinyang Song et al. NATURE IMMUNOLOGY
- Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings
- (2010) Thomas Andersen et al. RHEUMATOLOGY INTERNATIONAL
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin-17-Producing γδ T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals
- (2009) Bruno Martin et al. IMMUNITY
- Skin and Peripheral Lymph Node Invariant NKT Cells Are Mainly Retinoic Acid Receptor-Related Orphan Receptor t+ and Respond Preferentially under Inflammatory Conditions
- (2009) J.-M. Doisne et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
- (2009) Amit Awasthi et al. JOURNAL OF IMMUNOLOGY
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
- (2008) Ying Liu et al. PLoS Genetics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started